approach to pleura leffusion

download approach to pleura leffusion

of 91

Transcript of approach to pleura leffusion

  • 8/18/2019 approach to pleura leffusion

    1/91

    Pleural Effusion

    &Approach to the patient

    Dr.Muhammad Asim Rana

  • 8/18/2019 approach to pleura leffusion

    2/91

    Definition

     Pleural effusion is the accumulation of fluid in

    the pleural space.

    The pleural space lies between the lung and

    chest wall and normally contains a very thinlayer of fluid, which serves as a coupling

    system.

     A pleural effusion is present when there is an

    excess quantity of fluid in the pleural space.

  • 8/18/2019 approach to pleura leffusion

    3/91

    Etiology

    Normally, fluid enters the pleural space from

    the capillaries in the parietal pleura and is

    removed via the lymphatics situated in the

    parietal pleura. Fluid can also enter the pleural space from

    the interstitial spaces of the lung via the

    visceral pleura or from the peritoneal cavity

    via small holes in the diaphragm.

  • 8/18/2019 approach to pleura leffusion

    4/91

    Pleural fluid accumulates when pleural fluid formation

    exceeds pleural fluid absorption.

    The lymphatics have the capacity to absorb ! times

    more fluid than is normally formed. Accordingly, a

    pleural effusion may develop when there is excess

    pleural fluid formation "from the interstitial spaces of

    the lung, the parietal pleura, or the peritoneal cavity#

    or when there is decreased fluid removal by the

    lymphatics.

  • 8/18/2019 approach to pleura leffusion

    5/91

    Types of pleural effusion

  • 8/18/2019 approach to pleura leffusion

    6/91

    Transudative pleural effusions

      result from alteration of hydrostatic and

    oncotic factors that increase the formation or

    decrease the absorption of pleural fluid "e.g.,

    increased mean capillary pressure $heartfailure% or decreased oncotic pressure

    $cirrhosis or nephrotic syndrome%#.

  • 8/18/2019 approach to pleura leffusion

    7/91

     Exudative pleural effusions

      occur when damage or disruption of the

    normal pleural membranes or vasculature

    "e.g., tumor involvement of the pleural space,

    infection, inflammatory conditions, or trauma#leads to increased capillary permeability or

    decreased lymphatic drainage.

  • 8/18/2019 approach to pleura leffusion

    8/91

    Diagnostic Approach

  • 8/18/2019 approach to pleura leffusion

    9/91

    Clinical Presentation

     The underlying cause of the effusion usually

    dictates the symptoms, although patients may

    be asymptomatic.

     Pleural inflammation, abnormal pulmonarymechanics, and worsened alveolar gas

    exchange produce symptoms and signs of

    disease.

  • 8/18/2019 approach to pleura leffusion

    10/91

    symptoms and signs

     &nflammation of the parietal pleura leads to

     pain in local "intercostal# involved areas or

    referred "phrenic# distributions "shoulder#.

     Dyspnea is frequent and may be presentand out of proportion to the si'e of the

    effusion.

    Cough can occur.

  • 8/18/2019 approach to pleura leffusion

    11/91

    Chest examination is notable for 

    dullness to percussion, decreased or

    absent tactile fremitus, and decreased

    breath sounds.

     Tracheal shift to the contralateral side oran ipsilateral pleural rub may be present. 

  • 8/18/2019 approach to pleura leffusion

    12/91

    The clinical setting is crucial to establishing a proper

    diagnosis. A definitive diagnosis based solely upon

    pleural fluid analysis is possible in the minority of

    pleural effusions.

     (istory or physical examination findings suggestive

    of congestive heart failure, malignancy, pneumonia,

    pulmonary embolism, myocardial infarction, surgery,

    cirrhosis, or rheumatologic arthritis provide important

    clues to the underlying diagnosis.

  • 8/18/2019 approach to pleura leffusion

    13/91

    Laboratory and Imaging

    Studies

  • 8/18/2019 approach to pleura leffusion

    14/91

    Chest oentginogram

    Pleural effusions are typically detected by

    chest radiography as blunting of the

    costophrenic angle or opacification of the

    base of the hemithorax without loss of volumeof the hemithorax "which would suggest

    atelectasis#, and may be accompanied by air

    bronchograms "which would suggest an

    alveolar filling process such as pneumonia#.

  • 8/18/2019 approach to pleura leffusion

    15/91

    Prior to invasive diagnostic or therapeutic

    procedures, the patient should undergo

    imaging to confirm the presence and si'e of

    the effusion. Preferred modalities include)

  • 8/18/2019 approach to pleura leffusion

    16/91

    Decubitus chest radiography

    *howing layering fluid will confirm the

    presence of pleural effusion and

    demonstrates that at least a portion of the

    fluid is not loculated.

  • 8/18/2019 approach to pleura leffusion

    17/91

    Thoracic ultrasonography

    &s one of the best modalities to assess for

    pleural fluid loculations.

    +ltrasonography can also provide realtime

    guidance for pleural procedures and canreduce both the complication and failure rate

    of thoracentesis.

  • 8/18/2019 approach to pleura leffusion

    18/91

    Computed tomography of the chest

    -ith contrast helps differentiate pleural fluid

    from lung masses and atelectatic lung, and

    helps define the extent of pleural thicening,

    pleural nodularity, and other associatedfindings.

  • 8/18/2019 approach to pleura leffusion

    19/91

    Pleural fluid analysis

    Thoracentesis can be performed safely at thebedside, in the absence of disorders of hemostasis,on effusions that extend /0! mm from the inner chestwall on a lateral decubitus film.

    1oculated effusions can be locali'ed withultrasonography or 2T scan.

    Proper technique and sonographic guidanceminimi'e the ris of pneumothorax and othercomplications.

  • 8/18/2019 approach to pleura leffusion

    20/91

    The first step is to determine whether the

    effusion is a transudate or an exudate.

  • 8/18/2019 approach to pleura leffusion

    21/91

     A transudative pleural effusion occurs when

    systemic factors that influence the formation

    and absorption of pleural fluid are altered.

    The leading causes of transudative pleuraleffusions are left ventricular failure and

    cirrhosis.

  • 8/18/2019 approach to pleura leffusion

    22/91

     An exudative pleural effusion occurs when

    local factors that influence the formation and

    absorption of pleural fluid are altered. The

    leading causes of exudative pleural effusionsare bacterial pneumonia, malignancy, viral

    infection, and pulmonary embolism.

  • 8/18/2019 approach to pleura leffusion

    23/91

    The primary reason to mae this

    differentiation is that additional diagnostic

    procedures are indicated with exudative

    effusions to define the cause of the localdisease.

  • 8/18/2019 approach to pleura leffusion

    24/91

     -hile pleural effusion occurs in a vast arrayof disease states, 3!4 of pleural effusionsare the result of only five diseases.

     2ongestive heart failure "564#  Pneumonia "4#  7alignancy "084#  Pulmonary embolism "004#

     9iral disease ":4#

  • 8/18/2019 approach to pleura leffusion

    25/91

    Chec! pleural fluid for 

     Appearance,

    lactate dehydrogenase "1;(#,

    protein,

    p(,

    glucose and

    albumin

  • 8/18/2019 approach to pleura leffusion

    26/91

    *erum lactate dehydrogenase "1;(#, protein,

    p(, glucose and albumin should be

    measured within hour of the thoracentesis to

    allow appropriate comparison.

  • 8/18/2019 approach to pleura leffusion

    27/91

    Pleural fluid appearance

    7ost transudates are clear, straw colored,

    nonviscid, and without odor

  • 8/18/2019 approach to pleura leffusion

    28/91

    "loody pleural fluid

    &f the blood is due to thoracentesis, the

    degree of discoloration should clear during

    the aspiration.

    =loody pleural fluid usually indicates thepresence of malignancy, pulmonary embolism

    "P>#, or trauma.

  • 8/18/2019 approach to pleura leffusion

    29/91

    #emothorax

    The presence of gross blood should lead to

    the measurement of a pleural fluid

    hematocrit.

    (emothorax is defined as a pleural fluid toblood hematocrit ratio of /!.?, and chest tube

    drainage should be considered.

  • 8/18/2019 approach to pleura leffusion

    30/91

    >xudative pleural effusions meet at least one

    of the 1ight@s criteria , whereas transudative

    pleural effusions meet none)

  • 8/18/2019 approach to pleura leffusion

    31/91

    Light$s criteria

    "a# a pleural fluidtoserum protein ratio of

    /!.?,

    "b# a pleural fluidtoserum 1;( ratio of /!.6,

    "c# a pleural fluid 1;( of more than twothirdsof the upper limit of normal for serum 1;(

  • 8/18/2019 approach to pleura leffusion

    32/91

    The above criteria misidentify ?4 of

    transudates as exudates.

     &f one or more of the exudative criteria are

    met and the patient is clinically thought tohave a condition producing a transudative

    effusion, lie in whom clinical suspicion for

    heart, liver, or idney disease is high what

    should be doneB

  • 8/18/2019 approach to pleura leffusion

    33/91

    The difference between the protein levels in the

    serum and the pleural fluid should be measured.

    &f this gradient is greater than 50 gC1 "5.0 gCd1#, the

    exudative categori'ation by the above criteria can be

    ignored because almost all such patients have atransudative pleural effusion.

    &n some texts a gradient of /0. gCd1 suggests that

    the pleural fluid is transudate.

  • 8/18/2019 approach to pleura leffusion

    34/91

    If a patient has an exudati%e pleural

    effusion

    ;escription of the fluid, Dlucose level, ;ifferential cell count, 7icrobiologic studies, 2ytology. 2ultures, Triglycerides,  Amylase, and

    p(

  • 8/18/2019 approach to pleura leffusion

    35/91

    "C differential

    The -=2 differential is often not diagnostic,

    although neutrophilia is suggestive of

    infection.

  • 8/18/2019 approach to pleura leffusion

    36/91

    >osinophilia "/0!4 of total nucleated cellcount# is suggestive of air or blood in the

    pleural space. &f air or blood is not present inthe pleural space, consideration should begiven to fungal and parasitic infection, druginduced disease, P>, asbestosrelateddisease, and 2hurg*trauss syndrome.

  • 8/18/2019 approach to pleura leffusion

    37/91

    1ymphocytosis "/?!4 of the total nucleated

    cell count# is suggestive of malignancy or

    tuberculosis.

    7esothelial cells argues against thediagnosis of tuberculosis.

    Plasma cells suggest a diagnosis of multiple

    myeloma.

  • 8/18/2019 approach to pleura leffusion

    38/91

    >xudative effusions with normal protein but

    high 1;( are liely to be parapneumonic or

    secondary to malignancy.

    1;( is an indicator of the degree of pleuralinflammation.

  • 8/18/2019 approach to pleura leffusion

    39/91

    'lucose concentration

     A glucose concentration of E6! mgCd1 isprobably due to

    tuberculosis,

    malignancy, rheumatoid arthritis, or parapneumonic effusion. For parapneumonic pleural effusions with a

    glucose of E6! mgCd1, tube thoracostomyshould be considered.

  • 8/18/2019 approach to pleura leffusion

    40/91

    Pleural fluid (ith a lo( p#

     A p( of E:.5 is seen with

    empyema,

    tuberculosis,

    malignancy, collagen vascular disease, or

    esophageal rupture.

  • 8/18/2019 approach to pleura leffusion

    41/91

    For parapneumonic pleural effusions with a p( of

    E:.!, tube thoracostomy should be considered.

    Pleural fluid for p( testing should be collected

    anaerobically in a heparini'ed syringe and placed on

    ice. Pleural fluid with a low p( usually has a low glucose

    and a high 1;( otherwise, the low p( may be due to

    poor sample collection technique.

  • 8/18/2019 approach to pleura leffusion

    42/91

    Amylase

     An elevation of amylase suggests that the

    patient has pancreatic disease, malignancy,

    or esophageal rupture.

    7alignancy and esophageal rupture havesalivary amylase elevations and not

    pancreatic amylase elevations.

  • 8/18/2019 approach to pleura leffusion

    43/91

    Turbid or mil!y fluid

    should be centrifuged.

    &f the supernatant clears, the cloudiness is liely due

    to cells and debris.

    &f the supernatant remains turbid, pleural lipids should

    be measured. >levation of triglycerides "/00! mgCd1#

    suggests that a chylothorax is present, usually due to

    disruption of the thoracic duct from trauma, surgery,

    or malignancy "i.e., lymphoma#.

  • 8/18/2019 approach to pleura leffusion

    44/91

    Cytology

    2ytology is positive in approximately 6!4 ofmalignant effusions.

    Priming the fluid collection bag with

    unfractionated heparin "+F( e.g., 0,!!!&nternational +nits# may increase the yield. The volume of pleural fluid analy'ed does not

    impact the yield of cytologic diagnosis.

  • 8/18/2019 approach to pleura leffusion

    45/91

    Surgical diagnostic

     procedures

  • 8/18/2019 approach to pleura leffusion

    46/91

    Closed pleural biopsy

    2losed pleural biopsy adds little to the diagnostic

    yield of thoracentesis, except in the diagnosis of

    tuberculosis.

    For tuberculous effusions, pleural fluid cultures alone

    are positive in only !4 to ?4 of cases. (owever,the combination of pleural fluid studies and pleural

    biopsy "demonstrating granulomas or organisms# is

    3!4 sensitive in establishing tuberculosis as the

    etiology of the effusion.

  • 8/18/2019 approach to pleura leffusion

    47/91

    Diagnostic thoracoscopy

     ;iagnostic thoracoscopy has largely

    replaced closed pleural biopsy. Thoracoscopy

    allows directed biopsies that increase the

    diagnostic yield for malignancy whilemaintaining the high diagnostic yield of

    closed pleural biopsy for T=.

  • 8/18/2019 approach to pleura leffusion

    48/91

     Indications for diagnostic

    thoracoscopy

    Pleural effusion of unnown etiology

     7esothelioma

    1ung cancer

    Tuberculosis Gther benign pleural disorders

    Pulmonary parenchymal disease

  • 8/18/2019 approach to pleura leffusion

    49/91

     )ther diagnostic

     procedures

  • 8/18/2019 approach to pleura leffusion

    50/91

    Gther diagnostic procedures that are useful in

    establishing the etiology of a pleural effusion

    when the aforementioned tests are

    nondiagnostic include)

    >valuation of liver function

  • 8/18/2019 approach to pleura leffusion

    51/91

  • 8/18/2019 approach to pleura leffusion

    52/91

  • 8/18/2019 approach to pleura leffusion

    53/91

    Differential Diagnoses of

    Pleural Effusions

  • 8/18/2019 approach to pleura leffusion

    54/91

    Transudative Pleural Effusions

    0. 2ongestive heart failure

    . 2irrhosis

    5. Pulmonary emboli'ation

    8. Nephrotic syndrome?. Peritoneal dialysis

    6. *uperior vena cava obstruction

    :. 7yxedemaH. +rinothorax

  • 8/18/2019 approach to pleura leffusion

    55/91

    Exudative Pleural Effusions

    1. Neoplastic diseases

    a. 7etastatic disease

    b. 7esothelioma

  • 8/18/2019 approach to pleura leffusion

    56/91

    2. Infectious diseases

    a. =acterial infections

    b. Tuberculosis

    c. Fungal infectionsd. 9iral infections

    e. Parasitic infections

  • 8/18/2019 approach to pleura leffusion

    57/91

    3. Pulmonary emboliation  !. "astrointestinal disease

    a. >sophageal perforation

    b. Pancreatic diseasec. &ntraabdominal abscesses

    d. ;iaphragmatic hernia

    e. After abdominal surgery

    f. >ndoscopic variceal sclerotherapy

    g. After liver transplant

  • 8/18/2019 approach to pleura leffusion

    58/91

    #. Collagen$%ascular diseases 

    a.

  • 8/18/2019 approach to pleura leffusion

    59/91

    6. Postcoronary artery bypass surgery

    :. Asbestos exposure

    H. *arcoidosis

    3. +remia 0!. 7eigs@ syndrome

    00. Kellow nail syndrome

  • 8/18/2019 approach to pleura leffusion

    60/91

    12. Drug$induced pleural disease

    a. Nitrofurantoin

    b. ;antrolene

    c. 7ethysergided. =romocriptine

    e. Procarba'ine

    f. Amiodarone

  • 8/18/2019 approach to pleura leffusion

    61/91

    05. Trapped lung

    08.

  • 8/18/2019 approach to pleura leffusion

    62/91

    0:. &atrogenic inIury

    0H. Gvarian hyperstimulation syndrome

    03. Pericardial disease

    !. 2hylothorax

    *Cl i * d t th t b

  • 8/18/2019 approach to pleura leffusion

    63/91

    *Classic* exudates that can be

    transudates

    7alignancy)

      ;ue to early lymphatic obstruction, obstructive

    atelectasis, or concomitant disease "2(F#.

    Pulmonary embolism)

      5 percent incidence due to atelectasis.

    *arcoidosis)

    *tage && and &&& disease.

    (ypothyroid pleural effusion)From hypothyroid heart disease or hypothyroidism per

    se.

  • 8/18/2019 approach to pleura leffusion

    64/91

    Treatment

  • 8/18/2019 approach to pleura leffusion

    65/91

      Transudates resolve with treatment of the

    underlying heart, idney, or liver disease.

    +ncommonly, more aggressive approaches

    including pleurodesis and shunts arerequired.

  • 8/18/2019 approach to pleura leffusion

    66/91

    Parapneumonic effusions and empyema

    should be managed with tube drainage when

    indicated based on the si'e, gross

    appearance, or biochemical analysis of thepleural fluid or the presence of loculations

    7ultiple tubes are sometimes required to

    adequately drain the pleural space.

  • 8/18/2019 approach to pleura leffusion

    67/91

      Failure to adequately and quicly drain a

    complicated parapneumonic effusion can

    lead to organi'ation of the pleural fluid and

    formation of a thic pleural adhesions whichmay necessitate surgical removal nown as

    decortication.

  • 8/18/2019 approach to pleura leffusion

    68/91

    Indications for TubeThoracostomy in

    Parapneumonic Effusions

  • 8/18/2019 approach to pleura leffusion

    69/91

    Radiographic criteria

    Pleural fluid loculations

    >ffusion filling more than half the hemithorax

     Air fluid level

    Microbiologic criteria

  • 8/18/2019 approach to pleura leffusion

    70/91

    Microbiologic criteria

      Pus in the pleural space

    Positive stain for microorganisms

    Positive pleural fluid cultures

  • 8/18/2019 approach to pleura leffusion

    71/91

    Chemical criteria

    Pleural fluid p( E:.

    Pleural fluid glucose E6! mgCd1

  • 8/18/2019 approach to pleura leffusion

    72/91

    C)+TAI+DICATI)+S

    There are no absolute contraindications totube thoracostomy, particularly if the patient isin respiratory distress.

     Anticoagulation or a bleeding diathesis is arelative contraindication in a patientundergoing elective chest tube placement forpleurodesis. =lind insertion of a chest tube isdangerous in a patient with adhesions from

    infection, previous pleurodesis, or a lungtransplant guidance by 2T scan withoutcontrast is preferred in these patients.

  • 8/18/2019 approach to pleura leffusion

    73/91

    Type of tube

    *ilasticL tubes are preferred because older

    rubber tubes have fewer drainage holes, are

    not well visuali'ed on chest radiographs, and

    produce more pleural inflammation. *ilasticchest tubes contain a radiopaque strip with a

    gap that serves to mar the most proximal

    drainage hole.

  • 8/18/2019 approach to pleura leffusion

    74/91

    Si,e of tube

     A chest tube@s internal diameter and lengthare the critical determinants of flow.

    *elect the appropriate chest tube si'e to

    account for the viscosity and accumulationrate of the pleural material to be drained.

     As an example, drainage of viscous fluids

    requires a larger bore chest tube than that

    required for drainage of a similar volume ofair.

  • 8/18/2019 approach to pleura leffusion

    75/91

    Malignant effusionM A smallbore catheter "Hto 08 Fr# placed under ultrasound or 2Tguidance is usually adequate to drain amalignant pleural effusion and achieve

    pleurodesis.  Empyema M For a complicated

    parapneumonic effusion or empyema that isamenable to drainage with a single catheter.

    Prefer initial imageguided placement ofsmallbore catheters "0! to 08 Fr#, with orwithout intrapleural fibrinolytic agents.

  • 8/18/2019 approach to pleura leffusion

    76/91

    &t is preferred to use the smaller tube si'e asthis is generally more comfortable for

    patients, particularly if more than one tube is

    needed. Alternatively, when the fluid appears

    viscous, a larger bore tube "068 Fr# may be

    used.

  • 8/18/2019 approach to pleura leffusion

    77/91

    +nsuccessful drainage with a smallborecatheter either indicates the presence ofmultiple loculations or very viscous material.7ultiple smallbore catheters may be used in

    multiloculated effusions or large borecatheters in case of very viscous material.Failure to drain with a single smallbore tubeshould also lead to thoracic surgery

    consultation to avoid delays in case videoassisted thoracoscopy "9AT*# becomesnecessary.

  • 8/18/2019 approach to pleura leffusion

    78/91

    Hemothorax  M The goals of tubethoracostomy in acute hemothorax are

    drainage of fresh blood, quantification of the

    rate of bleeding, evacuation of any coexisting

    pneumothorax, and tamponade of the

    bleeding site. 1arge bore catheters "5 to 8!

    Fr# are required to reliably achieve these

    goals.

  • 8/18/2019 approach to pleura leffusion

    79/91

    Gnce a hemothorax is defibrinated in situ,that is after the acute phase, success of

    drainage is less dependent on the si'e of the

    tube, than on the degree and mode of clot

    formation. 1arge amounts of clotted blood

    should be evacuated via video assisted

    thoracoscopy.

  • 8/18/2019 approach to pleura leffusion

    80/91

    Gccasionally, a hemothorax may result in asonographically complex septate pattern and

    may be treated with smallbore catheters.

    Treatment of hemothorax should be

    individuali'ed and done in consultation with

    thoracic surgery.

  • 8/18/2019 approach to pleura leffusion

    81/91

    -alignant pleural effusions

    Gbservation without invasive interventionsmay be appropriate for some patients with

    malignant pleural effusions.

    Therapeutic thoracentesis may improvepatient comfort and relieve dyspnea. The

    rapid removal of more than 0 1 of pleural fluid

    may rarely result in reexpansion pulmonary

    edema, especially if the lung is unable to reexpand.

  • 8/18/2019 approach to pleura leffusion

    82/91

  • 8/18/2019 approach to pleura leffusion

    83/91

    Chemical pleurodesis

    2hemical pleurodesis is an effective therapyfor recurrent effusions. This treatment is

    recommended in patients whose symptoms

    are relieved with initial drainage but who have

    rapid reaccumulation of fluid.

    l l d i

  • 8/18/2019 approach to pleura leffusion

    84/91

    Talc pleurodesis

      >ffective and inexpensive.

    Fever and hypoxia are common following

    instillation of talc into the pleural space, and

    respiratory failure has been described onoccasion.

    Gverall efficacy is similar for talc slurry

    delivered via chest tube versus dry talc

    insufflated during thoracoscopy.

    D li i li

  • 8/18/2019 approach to pleura leffusion

    85/91

    Doxycycline or minocycline

    ;oxycycline or minocycline can also beinstilled into the pleural space via a chest

    tube.

    Pain is more prevalent and severe followingdoxycycline and minocycline than following

    talc.

    "l i

  • 8/18/2019 approach to pleura leffusion

    86/91

    "leomycin

    =leomycin appears to be less effective andmore expensive than other drugs.

  • 8/18/2019 approach to pleura leffusion

    87/91

    *ystemic analgesics and the administration oflidocaine in the sclerosing agent solution help

    to decrease the appreciable discomfort

    associated with the procedure.

    &f the chest tube drainage remains high "/0!!

    m1Cd# more than days after the initial

    pleurodesis, a second dose of the sclerosing

    agent can be administered.

    Ch i i d lli l l h

  • 8/18/2019 approach to pleura leffusion

    88/91

    Chronic ind(elling pleural catheters

    Provide good control of effusionrelated

    symptoms via intermittent drainage.

    The Pleurx catheter is better at controlling

    symptoms than doxycycline administered via achest tube. Furthermore, repeated drainage via

    a Pleurx catheter leads to pleurodesis in roughly

    ?!4 of patients, allowing the catheter to be

    removed.

    Pl t l l b i

  • 8/18/2019 approach to pleura leffusion

    89/91

     Pleurectomy or pleural abrasion

  • 8/18/2019 approach to pleura leffusion

    90/91

    C e ot e apy a d ed ast a

    radiotherapy

    7ay control effusions in responsive tumors, such

    as lymphoma or smallcell bronchogenic

    carcinoma, although it has poor efficacy inmetastatic carcinoma.

  • 8/18/2019 approach to pleura leffusion

    91/91

    Than! you %ery much